Global Biobank Market Is Expanding Due To Rising Genomic Research Efforts And Growing Application Areas Of Biobank Samples

Biobank Market
Biobank Market 

Overview:

Biobanking is a process of storing, testing and analyzing biological samples. It is the stewardship of biological specimens by a public institution. This is done in a way that the interests of the donors are respected. A biobank is a place where people can donate or receive tissue samples for research. These samples can support investigations into rare diseases, cancer, or other conditions. They can also be used to assess multifactorial genetic biomarkers.

Biobanking has become a complex infrastructure. These complex units handle bio specimens that have been donated by humans. Creating a biobank requires specific funding and the capacity to maintain and operate it. Biobanks differ in their size, research topic, and procedures for collecting and processing samples. It is therefore critical to create a clear mission and objective for the project. Most biobanks started as local units supporting research projects. Most are funded bsy public research grants. Some biobanks are national, while others are regional.

Market Dynamics:

Increasing partnerships among key players is estimated to augment growth of the global Biobank Market during the forecast period.

For instance, Biogen, Inc., and Partners HealthCare and Broad Institute of MIT, collaborated in April 2020, for building a COVID-19 biobank. Moreover, growing ethical challenges and lack of standardization is anticipated to restrain growth of the global biobank for market during the forecast period.

Impact of COVID-19:

COVID-19 was first reported in 2019 and it was transmitted to many other countries globally. The number of COVID-19 cases were increasing the risk of storing, collecting and processing human bio specimens was also growing. As these biological materials could lead to further transmission of the virus. Several companies that were collecting human cell samples for treating caner found that the samples to be infected. This resulted in decreasing demand and affected the growth of the market. Thus, the pandemic impacted the global biobank for market in a negative manner.

Key Takeaways:

The global Biobank Market is expected to witness high growth, exhibiting CAGR of XX% over the forecast period, due to increasing product launches. For instance, new sample storage tubes were launched by Hamilton Storage in February 2020 at the SLAS 2020 International Conference and Exhibition.

Over the course of the forecast period, a rise in the number of products available on the market is anticipated to fuel the growth of the global Bovine Plasma Market.

Europe is anticipated to witness significant growth in the global biobank for market over the forecast period, owing to rising investment and increasing processing of large-scale datasets.

Major players operating in the global Biobank Market are Precision Cellular Storage Ltd., Thermo Fisher Scientific, Inc, PromoCell GmbH, Merck KGaA, Lonza, QIAGEN, Charles River Laboratories, Hamilton Company, Taylor-Wharton, Avantor, BioCision, Tecan Trading AG., Becton, Dickinson and Company, and Danaher Corporation.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more